Cleveland State University

EngagedScholarship@CSU
Undergraduate Research Posters 2018

Undergraduate Research Posters

2018

Expression and purification of full-length recombinant
Plasmodium falciparum PfMC-2TM Maurer’s cleft protein
Alberto R. Williams-Medina
Cleveland State University

Kush Addepalli
Cleveland State University

Follow this and additional works at: https://engagedscholarship.csuohio.edu/u_poster_2018
Part of the Life Sciences Commons

How does access to this work benefit you? Let us know!
Recommended Citation
Williams-Medina, Alberto R. and Addepalli, Kush, "Expression and purification of full-length recombinant
Plasmodium falciparum PfMC-2TM Maurer’s cleft protein" (2018). Undergraduate Research Posters 2018.
22.
https://engagedscholarship.csuohio.edu/u_poster_2018/22

This Book is brought to you for free and open access by the
Undergraduate Research Posters at
EngagedScholarship@CSU. It has been accepted for
inclusion in Undergraduate Research Posters 2018 by an
authorized administrator of EngagedScholarship@CSU. For
more information, please contact library.es@csuohio.edu.
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Abstract
Malaria caused by Plasmodiumfalciparumremains the most virulent form of malaria, resulting
in 216 million cases and 445,000 deaths globally. Invasion of red blood cells by P.falciparum
leads to the formation of membranous structures known as Maurer's clefts (MC). Virulence
markers of P.falciparumsuch as PfEMP1 are transported across the MC to the surface of the
infected red blood cell. Insight into the formation and function of the MC will be important for
the discovery of new vaccine and drug candidates. The PfMC-2TM is encoded by a multi-gene
family of 13 members. PfMC-2TM is a protein localized to the MC. We induced expression of
PfMC-2TM encoded by 1 family member [PF3D7_0114100 (PFA0680c)] in BL21 DE3 strain of
Escherichia coli following transformation with recombinant pET-28a plasmid containing a
chemically synthesized gene. The purpose of this study was to determine immunogenic
properties of the resulting recombinant protein using western blot analysis. The recombinant
plasmid was isolated and analyzed in 1% agarose gel and an approximately 5kb band was
identified. Pilot expression of transformants showed expression of recombinant PfMC-2TM by
western blot. Recombinant PfMC-2TM protein will be expressed and purified for antibody
production to allow subsequent domain analysis and characterization.

Introduction
□

Figure 2. pET-28a(+) plasmid map showing available
Figure 1. General Plasmodium Life Cycle. Obtained from www.cdc.gov restriction sites and Kanamycin resistance gene.

Malaria
■
■
■

Figure 3. Sequence of chemically synthesized PfMC-2TM gene
containing added restrictions sites and pET-28a(+) plasmid
backbone.

216 million cases worldwide and 445,000 deaths worldwide (World Health
Organization, www.who.int/)
Infection transmitted by female Anophelesmosquito
Infection caused by Plasmodiumparasites (protozoans)
• P.falciparum-most virulent form
• P.ovale
• P.malariae
• P.knowlesi
• P.vivax

□ Plasmodiumfalciparum
■
■

■
■

□

Cause of Complicated/Severe Malaria
Only species that develops Maurer's clefts (MC)
• MC responsible for protein transport from red cell cytopalsmto erythrocyte
membrane (RBCM)
Virulence protein PfEMP1 is associated with knobs on the surface of RBC
PfMC-2TM is localized to the MC

Rationale
■

The rationale behind this project is to determine if the full-length chemically
synthesized gene, following bacterial transcription and subsequent translation,
can yield a protein with immunogenic properties.

Objectives and Hypothesis
□

Objectives
■

Transform DH5a strain E.coli bacteria with full-length pET-28a(+) PfMC-2TM
recombinant plasmid

■

Induce expression of the PfMC-2TM protein in BL21 DE3 strain of E. coli
Analyze bacterially synthesized protein by western blot analysis and determine
potential immunogenicity

■

□

Question
■ Do E. colitransformed with chemically synthesized PfMC-2TMrecombinant pET-

28a(+) plasmid yield an immunogenic PfMC-2TM protein?

□

Figure 4. Figure taken from Mundwiler-Pachlakto and Beck [1] (A) Light microscope
image from Georg Maurer's publication of Maurer's clefts. (B) Electron microscopy of
Maurer's clefts (scale bar 500nm).
Figure 5. Recombinant PfMC-2TM
pET-28a(+) plasmid isolated from
DH5a strain E. coli analyzed on 1%
agarose gel electrophoresis. DNA
ladder used was TrackItTM 1Kb Plus
DNA Ladder (Invitrogen). Plasmid
isolation was performed using the
Qiagen Plasmid Mini Kit. The
recombinant
plasmid
was
constructed
and
verified
by
GenScript (Piscataway, NJ) using
restriction enzyme analysis and
DNA sequencing to validate insert
location in the pET-28a plasmid
(seeplasmidmap).

Figure 6. BL21 DE3 growth curves and 1mM isopropylthiol-β-D-galactoside (IPTG) induction. Optical
density (OD) readings of bacteria broth cultures were done in triplicate and repeated twice by UV-Vis
Spectroscopy in Fixed View settings at 600nm. Readings were taken every 30 minutes for a total of 2
hours. Shaker/Incubator was set ata rangeof36-38oCandshakingintensity4.

Results and Conclusions

Hypothesis
■ E. colibacteria transformed with chemically synthesized PfMC-2TMrecombinant

- pET28a plasmid was isolated from DH5a E. coli cultures
- PfMC-2TM was successfully expressed in BL21-DE3 E. coli cultures
- Full-length recombinant PfMC-2TM reacted strongly with rabbit-anti-PfMC2TM antibodies

plasmid pET-28a(+) yield immunogenic PfMC-2TM protein

Methods
□
□
□

Transformed recombinant PfMC-2TMinto E. colistrains DH5a and BL21 DE3
Selected 4 DH5a and 6 BL21 DE3 transformants
Plated transformants on LB-Kanamycin plates and LB broth

Future Directions
- Repeat pilot expression to obtain more protein
- Express protein for purification
S Purified protein will be used for antibody production
S Antibodies will be used for domain and epitope characterization
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